Clinical Trials

35 enrolled

Melanoma

NCT02232516 2024-04-10

Romidepsin and Lenalidomide in Treating Patients With Previously Untreated Peripheral T-Cell Lymphoma

30 enrolled 17 charts

DermatologicLymphoid

Immunoblastic Lymphadenopathy, Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Extranodal NK-T-Cell

NCT06151847 2024-02-28

Lifileucel With Reduced Dose Fludarabine/Cyclophosphamide Lymphodepletion and Interleukin-2 for the Treatment of Patients With Unresectable or Metastatic Melanoma

12 enrolled

Melanoma

NCT05135715 2024-02-20

A Study of RC48-ADC in Advanced Melanoma Subjects With HER2 Variant (Mutation, Amplification, Overexpression)

50 enrolled

Melanoma

NCT02977052 2023-11-15

OpACIN-neo

186 enrolled

Melanoma

NCT05234658 2023-11-08

Study of an Artificial Human Skin Medicine for Patients With Basal Cell Carcinoma Undergoing Reconstructive Surgery

21 enrolled

Carcinoma, Basal Cell

NCT05370807 2023-10-24

RegoMel

48 enrolled

Melanoma

NCT04362722 2023-10-10

DUNCAN

Carcinoma, Carcinoma, Basal Cell

NCT05329792 2023-10-06

IntriNSiC

70 enrolled

DermatologicSarcoma

Carcinoma, Basal Cell, Carcinoma, Squamous Cell, Sarcoma, Kaposi, Carcinoma, Merkel Cell

NCT02858921 2023-08-30

Neo Trio

60 enrolled

Melanoma, Neoplasms

NCT03808441 2023-08-25

CAcTUS

21 enrolled

Melanoma

NCT05907512 2023-06-22

Endostar Plus Toripalimab as Adjuvant Therapy for Resectable Stage III-Oligometastatic Stage IV Cutaneous Melanoma

43 enrolled

Melanoma

NCT05106023 2023-06-07

To Explore the Efficacy and Safety of SHR-1701 Combined With Temozolomide in the Treatment of Advanced Melanoma

31 enrolled

Melanoma

NCT05263453 2023-05-31

HL-085+Vemurafenib to Treat Advanced Melanoma Patients With BRAF V600E/K Mutation

104 enrolled

Melanoma

NCT05823246 2023-05-26

Safety and Efficacy Study of QLF31907 in Advanced Melanoma and Urothelial Carcinoma

DermatologicGenitourinary

66 enrolled

Carcinoma, Transitional Cell, Melanoma

NCT05854589 2023-05-11

Effect of Topical Application of Hypertonic Saline on Melanoma on Its Sizes and Number.

20 enrolled

Melanoma

NCT05827770 2023-04-25

The Efficacy and Safety of Neoadjuvant Toripalimab Combined With Temozolomide in Resectable Stage III Melanoma

20 enrolled

Melanoma

NCT03528408 2023-04-11

Study of Adjuvant Ipilimumab and Nivolumab in Subjects With High-risk Ocular Melanoma

52 enrolled

Uveal Melanoma, Melanoma

NCT03769285 2023-04-06

SPRINTR-Pilot

120 enrolled

Carcinoma, Basal Cell, Carcinoma, Squamous Cell

NCT03132675 2023-03-27

Keynote-695

143 enrolled

Melanoma

NCT05767879 2023-03-14

(Neo)Adjuvant BRAF/MEK Inhibition in pN1c Melanoma

28 enrolled

Melanoma

NCT05429866 2023-03-08

Immunological Variables Associated to ICI Toxicity in Cancer Patients

BreastDermatologicGastrointestinalGenitourinaryHead & NeckOther solid neoplasmThoracic

441 enrolled

Mesothelioma, Malignant, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Melanoma, Carcinoma, Merkel Cell, Small Cell Lung Carcinoma

NCT05740969 2023-02-23

PACKS

48 enrolled

Keratosis, Actinic

NCT03913923 2023-02-10

OBERTON

117 enrolled

Melanoma

NCT05664139 2023-02-08

Recombinant Human Adenovirus Type 5 Injection Combined With PD-1 Monoclonal Antibody and Nab-paclitaxel in the Treatment of Patients With Liver Metastases From Malignant Melanoma

30 enrolled

Melanoma

NCT04633902 2022-12-06

Phase II Study of Olaparib and Pembrolizumab in Advanced Melanoma With Homologous Recombination (HR) Mutation

41 enrolled

Melanoma

NCT05077280 2022-12-06

A Study of Concurrent Stereotactic Body Radiotherapy With Opdualag in Metastatic Uveal Melanoma

Uveal Melanoma, Neoplasm Metastasis

NCT05051865 2022-11-17

To Explore the Efficacy and Safety of Camrelizumab Combined With SHR1020 in the Treatment of Advanced Melanoma

60 enrolled

Melanoma

NCT05406466 2022-11-10

Cryoablation Combined With Tislelizumab Plus Lenvatinib in Patients With Melanoma Liver Metastasis

25 enrolled

Melanoma

NCT02036086 2022-10-27

Study of Neo-adjuvant Use of Vemurafenib Plus Cobimetinib for BRAF Mutant Melanoma With Palpable Lymph Node Metastases

24 enrolled

Melanoma

NCT04913025 2022-09-21

REFINE

DermatologicGenitourinary

160 enrolled

Carcinoma, Renal Cell, Melanoma

NCT04929535 2022-08-30

Hydrogen Peroxide Trial to Investigate the Efficacy of 30%H2O2 as a Topical Application Before Definitive Treatment

51 enrolled

Carcinoma, Basal Cell

NCT03780608 2022-06-15

This Study is a Phase II Study of AZD6738 in Combination With Durvalumab in Patients With Solid Tumor (Cohort A (N=30): GC Who Have Failed Secondary Chemotherapy Treatments Regimen; Cohort B (B=30): Melanoma Patients Who Have Failed to IO)

61 enrolled

Melanoma

NCT05104801 2021-11-04

Sitravatinib With or Without Tislelizumab in Patients With Unresectable or Metastatic Melanoma

37 enrolled

Melanoma

NCT05097378 2021-10-28

PREMIUM

45 enrolled

Melanoma, Neoplasms

NCT03925350 2021-10-22

Efficacy and Safety Study of Niraparib in Melanoma With Genetic Homologous Recombination (HR) Mutation

41 enrolled

Melanoma

NCT04979585 2021-08-03

Camrelizumab Plus Amlotinib and Chemotherapy in the First-line Treatment of Melanoma

66 enrolled

Melanoma

NCT04928365 2021-06-16

Evaluation of Cytokine Biomarkers in Melanoma Patients During Immunotherapy

50 enrolled

Melanoma

NCT04884997 2021-05-13

A Study of Toripalimab or Combining With Temozolomide（iv） in the Treatment of Advanced/Metastatic Malignant Melanoma

90 enrolled

Melanoma

NCT03313323 2021-04-15

Zirconipi

29 enrolled

Melanoma

NCT02501551 2021-04-05

Regorafenib, C-kit Mutated Malignant Melanoma, 2nd Line Therapy

36 enrolled

Melanoma

NCT02617849 2021-02-18

Pembrolizumab With Carboplatin/Paclitaxel in Patients With Metastatic Melanoma

30 enrolled

Melanoma

NCT04749485 2021-02-11

A Study of HX008 for the Treatment of Patients With Malignant Melanoma

119 enrolled

Melanoma

NCT04593485 2020-12-23

Anti-PD-1 Antibody in the Treatment of Patients With Malignant Melanoma of the Female Genital Tract

Melanoma

NCT03013101 2020-09-30

Safety and Efficacy of Recombinant Humanized Anti-PD-1 mAb for Patients With Locally Advanced or Metastatic Melanoma

128 enrolled

Melanoma, Neoplasm Metastasis

NCT03269565 2020-09-18

MIRACULUM

126 enrolled

Melanoma

NCT03544723 2020-06-09

Safety and Efficacy of p53 Gene Therapy Combined With Immune Checkpoint Inhibitors in Solid Tumors.